Unraveling the contribution of gut microbiome in trichloroethene-mediated autoimmunity
揭示肠道微生物组在三氯乙烯介导的自身免疫中的作用
基本信息
- 批准号:10927562
- 负责人:
- 金额:$ 15.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-22 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:16S ribosomal RNA sequencingAccelerationAdoptive TransferAffectAntibioticsAntioxidantsAutoimmune DiseasesAutoimmune ResponsesAutoimmunityCD4 Positive T LymphocytesCecumCellsChemicalsCirculationColonDataDevelopmentDiseaseDisease MarkerDisease OutcomeDisease ProgressionEndotoxinsEnvironmentEnvironmental PollutantsEnvironmental Risk FactorEpitheliumEquilibriumEtiologyExposure toFOXP3 geneFecesFemaleFunctional disorderGenesGeneticGerm-FreeGoalsHistologyHormonalHumanIL17 geneImmuneImmune systemImpairmentIndustrializationInflammasomeInflammatoryInflammatory ResponseInterleukin-1 betaInterleukin-10Interleukin-6Intestinal permeabilityIntestinesKidneyKnowledgeLactobacillusLeadLeucocytic infiltrateLifeLinkMeasuresMediatingMetabolicMetabolismMetalsMorphologyMucosal ImmunityMucous MembraneMusOccupationalOrganic solvent productOxidative StressPathogenesisPathogenicityPathologicPermeabilityPhenotypePlayPopulationPredispositionProbioticsProcessProteinsRegulatory T-LymphocyteRibosomal RNARoleSamplingSerumSignal TransductionSourceSupplementationSystemic Lupus ErythematosusT-LymphocyteTNF geneTestingTherapeuticTight JunctionsTimeTrichloroethyleneVolatile Fatty Acidschronic autoimmune diseasecytokinedesigndysbiosisfatty acid supplementationfecal transplantationfeedinggut dysbiosisgut homeostasisgut microbiomegut microbiotahost microbiomein vivoinnovationinsightintestinal homeostasislupus-likemetagenomic sequencingmicrobialmicrobiomemicrobiome alterationmicrobiome compositionmicrobiotanovelnovel therapeuticspathogenic microbepreventprobiotic therapysystemic inflammatory responsetransmission processwhole genome
项目摘要
ABSTRACT
Trichloroethene (trichloroethylene, TCE), an environmental and occupational agent, is known to cause
autoimmune diseases (ADs), including SLE-like disease in humans. The etiology of SLE is likely multifactorial,
which includes genetic, hormonal and environmental triggers. There is increasing evidence that environmental
factors, including changes in microbiota contribute to ADs. Using female MRL+/+ mice, we have established
that TCE causes early induction of the disease. Our preliminary studies in these mice also show that TCE
exposure leads to gut microbiome dysbiosis along with decreases in several important bacterial short-chain
fatty acids (SCFAs). However, the contribution and mechanisms by which gut microbiota lead to TCE-mediated
early induction of SLE are not known, and are the major focus of this proposal. We will test the central
hypothesis that TCE exposure in genetically susceptible populations causes gut microbiome dysbiosis and
impaired intestinal integrity together with mucosal immune dysregulation, which contribute to systemic
autoimmune responses and eventually lead to SLE. To achieve our overarching goal of understanding the role
of gut microbiome in TCE-mediated SLE, the following specific aims will be pursued. Aim 1 will establish that
TCE exposure causes its SLE-producing effects via dysbiosis of gut microbiota, and gut microbiota from TCE-
treated MRL+/+ mice can transmit SLE phenotypes to control mice. Using fecal samples, 16S rRNA and
metagenomic sequencing (WGS) will be performed to assess differential composition of the gut microbiome,
and differences in the functional genes. Furthermore, using feces from TCE-treated mice, fecal microbiome
transplant (FMT) studies will be performed in germ-free mice, which will firmly establish that altered
microbiome plays a causative role in TCE-mediated autoimmunity. Aim 2 will determine if TCE-microbiome-
host interactions contribute to disease outcome by affecting intestinal integrity and mucosal immunity. We will
measure gut permeability in vivo, tight junction proteins and endotoxin levels in the circulation. Contribution of
oxidative stress to epithelial permeability will also be assessed. We will also determine if TCE treatment skews
the Treg-Th17 balance towards a Th17 phenotype, along with intestinal inflammasome activation and
inflammatory cytokines. Adoptive transfer of Tregs will then be done to restore gut homeostasis. Aim 3 will
determine if imbalances in bacterial SCFAs contribute to SLE pathogenesis by affecting mucosal immunity and
barrier functions, and probiotic therapy can ameliorate TCE-mediated autoimmunity by restoring SCFAs. We
will examine profiles of SCFAs and mucosal Tregs during initiation and progression of the disease, and
conduct supplementation studies with SCFAs and probiotics to further establish the mechanisms by which
microbiota contributes to TCE-mediated SLE. Successful completion of these aims will establish the causal
role of gut microbiome dysbiosis in TCE-mediated SLE, delineate novel mechanisms contributing to disease
pathogenesis, and help in designing novel therapeutic microbial targets for autoimmunity/SLE.
摘要
三氯乙烯(三氯乙烯,TCE)是一种环境和职业性试剂,已知会导致
自身免疫性疾病(AD),包括人类的SLE样疾病。SLE的病因可能是多因素的,
包括基因荷尔蒙和环境因素越来越多的证据表明,环境
因素,包括微生物群的变化有助于AD。使用雌性MRL+/+小鼠,我们建立了
三氯乙烯导致疾病的早期诱发。我们对这些小鼠的初步研究也表明,TCE
暴露导致肠道微生物组生态失调沿着几种重要的细菌短链
脂肪酸(SCFAs)。然而,肠道微生物群导致TCE介导的
SLE的早期诱导是未知的,并且是本建议的主要焦点。我们将测试中央
假设遗传易感人群中的TCE暴露导致肠道微生物组生态失调,
肠道完整性受损以及粘膜免疫失调,导致全身性
自身免疫反应最终导致SLE为了实现我们的首要目标,
TCE介导的SLE中的肠道微生物组,将追求以下具体目标。目标1将规定,
TCE暴露通过肠道微生物群的生态失调引起其产生SLE的效应,而TCE引起的肠道微生物群
经处理的MRL+/+小鼠可将SLE表型传递给对照小鼠。使用粪便样本,16 S rRNA和
将进行宏基因组测序(WGS)以评估肠道微生物组的差异组成,
和功能基因的差异。此外,使用TCE处理小鼠的粪便,
移植(FMT)研究将在无菌小鼠中进行,这将坚定地建立改变的
微生物组在TCE介导的自身免疫中起致病作用。目标2将确定TCE-微生物组-
宿主相互作用通过影响肠道完整性和粘膜免疫而促成疾病结果。我们将
测量体内肠道通透性、紧密连接蛋白和循环中的内毒素水平。贡献
还将评估氧化应激对上皮通透性的影响。我们还将确定TCE治疗是否存在偏差,
Treg-Th 17平衡向Th 17表型,沿着肠道炎性小体活化,
炎性细胞因子然后进行TdR的连续转移以恢复肠道稳态。目标3将
确定细菌SCFA的失衡是否通过影响粘膜免疫而导致SLE发病,
屏障功能,益生菌治疗可以通过恢复SCFA来改善TCE介导的自身免疫。我们
将检查疾病开始和进展期间SCFAs和粘膜T细胞的概况,
进行SCFAs和益生菌的补充研究,以进一步建立机制,
微生物群有助于TCE介导的SLE。成功地完成这些目标将建立因果关系
肠道微生物群失调在TCE介导的SLE中的作用,描述了导致疾病的新机制
致病机制,并帮助设计新的治疗性微生物靶点的自身免疫/SLE。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M. FIROZE KHAN其他文献
M. FIROZE KHAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M. FIROZE KHAN', 18)}}的其他基金
Trichloroethene Exposure and Autoimmune Hepatitis
三氯乙烯暴露与自身免疫性肝炎
- 批准号:
9333030 - 财政年份:2017
- 资助金额:
$ 15.82万 - 项目类别:
Xenobiotics, Lipid Peroxidation and Autoimmunity
异生素、脂质过氧化和自身免疫
- 批准号:
6855404 - 财政年份:2005
- 资助金额:
$ 15.82万 - 项目类别:
相似海外基金
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 15.82万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 15.82万 - 项目类别:
Continuing Grant
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 15.82万 - 项目类别:
Research Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 15.82万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 15.82万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 15.82万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 15.82万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 15.82万 - 项目类别:
Standard Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 15.82万 - 项目类别:
Continuing Grant
Radiation GRMHD with Non-Thermal Particle Acceleration: Next-Generation Models of Black Hole Accretion Flows and Jets
具有非热粒子加速的辐射 GRMHD:黑洞吸积流和喷流的下一代模型
- 批准号:
2307983 - 财政年份:2023
- 资助金额:
$ 15.82万 - 项目类别:
Standard Grant